Catalyst Wire Dossier Catalyst Wire Dossier

CINVANTI

aprepitant · Heron Therapeutics, Inc.
Drug timelines are a Plus or Pro feature.

5 regulatory and trial events tracked for CINVANTI, covering 2017-11-09 to 2024-03-05. Get the full timeline:

Most recent: FDA Approved: CINVANTI — Supplemental Application (Heron Therapeutics, Inc.)

See pricing